CenterBook Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$863K Buy
19,768
+5,005
+34% +$232K 0.04% 486
2026
Q2
$630K Buy
+14,763
New +$802K 0.03% 470
2026
Q1
– Sell
-24,725
Closed -$2.36M – 661
2025
Q4
$2.36M Sell
24,725
-776
-3% -$76.1K 0.12% 236
2025
Q3
$2.49M Buy
25,501
+5,708
+29% +$591K 0.12% 223
2025
Q2
$2.13M Sell
19,793
-6,998
-26% -$708K 0.12% 210
2025
Q1
$2.7M Buy
26,791
+13,979
+109% +$1.41M 0.17% 155
2024
Q4
$1.14M Buy
+12,812
New +$1.13M 0.07% 314
2022
Q3
– Sell
-9,821
Closed -$366K – 395
2022
Q2
$366K Buy
9,821
+1,837
+23% +$74.8K 0.08% 307
2022
Q1
$354K Buy
7,984
+2,009
+34% +$87.1K 0.13% 261
2021
Q4
$254K Buy
+5,975
New +$251K 0.15% 228

Other funds holding BSX

CenterBook Partners's BSX Position: Q3 2026 in Review

CenterBook Partners increased its Boston Scientific (BSX) stake by 34% in Q3 2026, buying an estimated $232K and bringing the position to 19,768 shares worth $863K. The position accounts for 0.04% of the portfolio, ranked #486.

CenterBook Partners first reported a position in BSX in Q4 2021 and has held it in 10 quarters since. The position peaked at $2.7M in Q1 2025. 777 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • CenterBook Partners held 19,768 shares of Boston Scientific worth $863K as of Q3 2026.
  • CenterBook Partners bought 5,005 Boston Scientific shares in Q3 2026, an estimated $232K.
  • Boston Scientific made up 0.04% of CenterBook Partners's portfolio in Q3 2026, its #486 holding.
  • CenterBook Partners first reported a position in Boston Scientific in Q4 2021 and has held it in 10 quarters since.
  • CenterBook Partners's Boston Scientific position peaked at $2.7M in Q1 2025.
  • 777 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.